CTT Pharmaceutical Holdings Inc
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.… Read more
CTT Pharmaceutical Holdings Inc (CTTH) - Total Assets
Latest total assets as of June 2025: $102.17K USD
Based on the latest financial reports, CTT Pharmaceutical Holdings Inc (CTTH) holds total assets worth $102.17K USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CTT Pharmaceutical Holdings Inc - Total Assets Trend (1999–2024)
This chart illustrates how CTT Pharmaceutical Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CTT Pharmaceutical Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
CTT Pharmaceutical Holdings Inc's total assets of $102.17K consist of 0.2% current assets and 99.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $72.93K | 99.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1999–2024)
This chart illustrates how CTT Pharmaceutical Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CTT Pharmaceutical Holdings Inc's current assets represent 0.2% of total assets in 2024, a decrease from 100.0% in 1999.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2024, down from 5.5% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 99.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is intangible assets at 99.8% of total assets.
CTT Pharmaceutical Holdings Inc Competitors by Total Assets
Key competitors of CTT Pharmaceutical Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
CTT Pharmaceutical Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - CTT Pharmaceutical Holdings Inc generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CTT Pharmaceutical Holdings Inc is currently not profitable relative to its asset base.
CTT Pharmaceutical Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 0.00 | 0.48 |
| Quick Ratio | 1.62 | 0.00 | 0.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $12.41K | $ -18.39K | $ -105.86K |
CTT Pharmaceutical Holdings Inc - Advanced Valuation Insights
This section examines the relationship between CTT Pharmaceutical Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.64 |
| Latest Market Cap to Assets Ratio | 20.45 |
| Asset Growth Rate (YoY) | -7.9% |
| Total Assets | $73.04K |
| Market Capitalization | $1.49 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CTT Pharmaceutical Holdings Inc's assets at a significant premium ( 20.45x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: CTT Pharmaceutical Holdings Inc's assets decreased by 7.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CTT Pharmaceutical Holdings Inc (1999–2024)
The table below shows the annual total assets of CTT Pharmaceutical Holdings Inc from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $73.04K | -7.92% |
| 2023-12-31 | $79.33K | -15.49% |
| 2022-12-31 | $93.86K | -12.85% |
| 2021-12-31 | $107.70K | -71.34% |
| 2020-12-31 | $375.83K | -34.43% |
| 2019-12-31 | $573.15K | -26.65% |
| 2018-12-31 | $781.45K | +318.92% |
| 2017-12-31 | $186.54K | +87.24% |
| 2016-12-31 | $99.62K | -84.52% |
| 2015-12-31 | $643.62K | -61.28% |
| 2014-12-31 | $1.66 Million | +378571.98% |
| 2014-02-28 | $439.00 | -92.98% |
| 2013-12-31 | $6.25K | -96.92% |
| 2012-12-31 | $203.08K | -95.15% |
| 2011-12-31 | $4.18 Million | +231.39% |
| 2010-12-31 | $1.26 Million | +17.40% |
| 2009-12-31 | $1.08 Million | -30.61% |
| 2008-12-31 | $1.55 Million | -16.64% |
| 2007-12-31 | $1.86 Million | +7.59% |
| 2006-12-31 | $1.73 Million | -19.95% |
| 2005-12-31 | $2.16 Million | -0.52% |
| 2004-12-31 | $2.17 Million | +34.45% |
| 2003-12-31 | $1.61 Million | +305.07% |
| 2002-12-31 | $398.34K | +1896761.90% |
| 2001-12-31 | $21.00 | -79.41% |
| 2000-12-31 | $102.00 | -97.45% |
| 1999-12-31 | $4.00K | -- |